Jim Cramer on AstraZeneca: “We Want Every Drug Stock”

Group 1 - AstraZeneca PLC (NASDAQ:AZN) is highlighted in Jim Cramer's game plan, indicating strong interest in the stock as part of a heavy earnings rotation alongside other major companies [1] - The company manufactures prescription medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and rare diseases [3] - Cramer expressed a positive outlook on AstraZeneca's cancer franchise, suggesting that it is stronger than previously anticipated, and recommended holding onto the stock over AbbVie [3] Group 2 - There is a recognition of AstraZeneca's potential as an investment, but some analysts believe that certain AI stocks may offer greater upside potential with less downside risk [4]